Experiences on the Treatment of Locally Advanced Basal Cell Carcinoma with Vismodegib

Basal cell carcinoma (BCC) is the most common skin cancer. At early stages, various topical treatments or light surgical procedures will give effective results. However, when the commonly used treatments are not appropriated, the hedgehog signaling inhibitor may be considered. We describe our experience on the treatments of locally advanced BCCs with vismodegib.